Newsletter Subscribe

Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Promising Results for First Topical Treatment in DR

Exonate Ltd., a pioneering mRNA therapy company specializing in treatments for diabetic diseases, has announced that its lead ophthalmology asset, EXN407, successfully met prespecified endpoints in a phase Ib/IIa study for diabetic retinopathy and diabetic macular edema. During the trial,…

Nidek, Orbis Collaborate to Boost AI Eye Screenings in Vietnam

Nidek has pledged support to Orbis International through a donation aimed at enhancing artificial intelligence (AI) screening services in Vietnam. The donation comprises six specialized fundus cameras, designed to capture retina images, thereby aiding the expansion of Orbis’s AI-driven diabetic…

Researchers Develop Game-Changing Eye Drops for DME

After 30 years of dedicated work, two researchers have achieved a remarkable breakthrough by developing eye drops that can effectively reach the back of the eye. This groundbreaking development paves the way for needle-free treatments of blinding retinal diseases, such…

Vyjuvek Restores Vision in Teen with Rare Genetic Condition

Krystal Biotech’s topical gene therapy Vyjuvek (beremagene-geperpavec) has successfully restored the vision of a 13-year-old boy suffering from the rare genetic condition dystrophic epidermolysis bullosa (DEB), which scarred his eyes. The groundbreaking case, detailed in a recent publication in The…

Eyenovia’s Redwood City Facility Clears FDA Inspection

Eyenovia announced the successful completion of the FDA inspection for its facility in Redwood City, California, marking a significant milestone in the company’s manufacturing capabilities. This achievement signals the green light for the facility to engage in final assembly, packaging,…

WashU Granted $20M for Eye Disease Screening Device

Washington University in St. Louis has been granted up to $20 million by the Advanced Research Projects Agency for Health (ARPA-H) to spearhead the development of a novel portable device aimed at revolutionizing the detection of eye diseases. The initiative,…

Novel Protocol to Rapidly Diagnose Eye Stroke

Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have pioneered a novel protocol aimed at swiftly diagnosing eye stroke and expediting care to prevent irreversible vision loss. Published in Ophthalmology, their study outlines the use of…

Oculus, Mainline Instruments Forge UK, Ireland Distribution Pact

In a move signaling a strategic expansion, Mainline Instruments and Oculus Optikgeräte have announced the extension of their successful partnership into the ophthalmology sector for the UK and Ireland markets. This collaboration aims to introduce cutting-edge ophthalmic solutions, catering to…

Stay informed and not overwhelmed, subscribe now!